News

New publication highlights role of EyeBOX concussion test in getting patients to appropriate therapy more quickly

Oculogica Inc. is pleased to highlight a publication this week by a team of concussion researchers on the value of the EyeBOX concussion diagnostic technology in patients with persisting post-concussive symptoms. The study, Metrics of concussion-related vision disorders among children and adolescents with persisting post-concussive symptoms using an objective eye tracking device, was published in the Journal [...]

XcelABLE and Oculogica® Partner to include EyeBOX® Concussion Diagnostics in Medical Evaluations

XcelABLE, a global provider of Functional Capacity Evaluations (FCEs) and Independent Medical Examinations (IMEs), has partnered with Oculogica, developer of the EyeBOX concussion test. EyeBOX has the most FDA clearances of any concussion test, and is the subject of multiple peer-reviewed publications. It was the first concussion test cleared by FDA for use without a

Royal Spine Surgery Clinic in Arizona Acquires New Technology to Better Assess Concussion

Scottsdale, AZ –06/05/2025- Royal Spine Surgery in Scottsdale, AZ is the latest clinic in Arizona to offer a new test to diagnose concussion, EyeBOX® manufactured by the Wisconsin based company, Oculogica. The test is based on eye-tracking technology and is the first FDA approved test for concussion that does not require a pre-injury baseline test.

Ontario Researchers to Pioneer New Concussion Diagnostic Tool in Canada

The TRANSCENDENT Concussion Research Program, led by Ontario-based researchers, is the first and only site in Canada to offer the newest test for concussion, EyeBOX®. TRANSCENDENT is a research collaboration funded by the Ontario Brain Institute and supported by the CHEO (Children’s Hospital of Eastern Ontario) Research Institute and 360 Concussion Care, a multi-specialty concussion

FDA approves broadest label in the industry for Oculogica’s EyeBOX® Concussion Diagnostic

Oculogica Inc., a pioneer in the development of non-invasive, objective diagnostic tools for brain injuries, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted an expanded label for its groundbreaking EyeBOX® technology. The updated label permits clinicians to compare a patient with an injury against a normative population, allowing physicians

EyeBOX Featured in HealthCare Plus 24 Magazine

EyeBOX was recently featured in HealthCare Plus 24 Magazine in an article about Erika Jordan, DMS, EMT, CHT, Founder and Director of the Hyperbaric Healing Treatment Center with two locations – in Orlando, FL and New Smyrna Beach, FL. Erika discusses how EyeBOX has helped her provide the most advanced technology and objective data to

CEO Dr. Rosina Samadani featured on NPR’s MorningMarketplace

We’re thrilled to share that Oculogica’s CEO, Rosina Samadani, Ph.D., was featured on NPR’s Morning Marketplace podcast! In the episode, Dr. Samadani discusses EyeBOX, the first FDA cleared tool to aid in the diagnosis of concussion without a pre-injury baseline, and how it is transforming concussion diagnosis.

EyeBOX Receives Health Canada Approval for Concussion Diagnosis Technology

Oculogica is proud to announce that Health Canada has approved the EyeBOX concussion diagnostic, an innovative device designed to assist healthcare providers in the diagnosis of concussions. This regulatory approval marks a major milestone for EyeBOX, which will now be available to healthcare professionals throughout Canada to help quickly and accurately assess mild traumatic brain

Oculogica’s EyeBOX shines in new study published in Military Medicine

August 20, 2024, New Richmond, WI Oculogica Inc. is pleased to highlight a publication this week by a Department of Defense based research team on the company’s EyeBOX concussion diagnostic technology. The study, Comparative Performance of Three Eye-Tracking Devices in Detection of Mild Traumatic Brain Injury in Acute Versus Chronic Subject Populations, was published in Military Medicine on August 17,

In New Richmond, AI technology to help diagnose concussions

When you suffer a concussion the real danger lies in not treating it seriously and failing to get it diagnosed by a doctor.  Rosina Samadani is the CEO of Oculogica, the New Richmond-based manufacturer of EyeBOX, an innovative medical device that evaluates eye movements to detect clues about cranial performance related to the impact from a.